July 24, 2024

2 Minutes
Medicine

Sirnaomics announces completion of IND-Enabling studies of safety and efficacy for STP125G with NHP models

Sirnaomics, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for STP125G, an siRNA therapeutics targeting Apolipoprotein C3 (ApoC3), based on...
Read More